New Pancreatic Ductal Adenocarcinoma Research Published in Journal of Visualized Experiments
November 15, 2018 08:00 ET
|
Crown Bioscience
Paper describes well-established protocols for PDAC orthotopic tumor homograft model development and immunoprofiling SAN DIEGO, Nov. 15, 2018 (GLOBE NEWSWIRE) -- Crown Bioscience, a global drug...
Crown Bioscience Expands Cardiovascular & Metabolic Disease Research Capability
November 08, 2018 08:00 ET
|
Crown Bioscience
The Company Offers New Non-GLP Services & Translational Rodent Models at its expanded site in Louisiana SAN DIEGO, Nov. 08, 2018 (GLOBE NEWSWIRE) -- Crown Bioscience, a global drug...
CrownBio Completes Validation of Prostate Cancer Patient-Derived Xenograft (PDX) Models
September 26, 2018 08:00 ET
|
Crown Bioscience
SAN DIEGO, Sept. 26, 2018 (GLOBE NEWSWIRE) -- Crown Bioscience, a global drug discovery and development services company providing translational platforms to advance oncology, inflammation,...
CrownBio Licenses Translational Breast Cancer Models of Resistance and Metastasis
September 18, 2018 08:00 ET
|
Crown Bioscience
SAN DIEGO, Sept. 18, 2018 (GLOBE NEWSWIRE) -- Crown Bioscience, a global drug discovery and development services company providing translational platforms to advance oncology, inflammation,...
CrownBio erweitert gentechnisch veränderte Modellauswahl durch strategische Partnerschaft mit dem Shanghai Model Organisms Center (SMOC)
August 14, 2018 23:50 ET
|
Crown Bioscience
SAN DIEGO, Aug. 15, 2018 (GLOBE NEWSWIRE) -- Crown Bioscience, ein globales Unternehmen im Bereich der Forschung und Entwicklung von Arzneimitteln, das translationale Plattformen zur...
CrownBio étend sa sélection de modèles génétiquement modifiés grâce à une alliance stratégique avec le Shanghai Model Organisms Center (SMOC)
August 14, 2018 23:50 ET
|
Crown Bioscience
SAN DIEGO, 15 août 2018 (GLOBE NEWSWIRE) -- Crown Bioscience, une société mondiale de services de recherche et de développement de médicaments fournissant des plateformes translationnelles en...
CrownBio Expands Genetically Engineered Model Selection Via Strategic Alliance with Shanghai Model Organisms Center (SMOC)
August 14, 2018 08:00 ET
|
Crown Bioscience
SAN DIEGO, Aug. 14, 2018 (GLOBE NEWSWIRE) -- Crown Bioscience, a global drug discovery and development services company providing translational platforms to advance oncology, inflammation,...